The latest closing stock price for Aquestive Therapeutics as of March 07, 2025 is 2.65.
An investor who bought $1,000 worth of Aquestive Therapeutics stock at the IPO in 2018 would have $-835 today, roughly -1 times their original investment - a -22.69% compound annual growth rate over 7 years.
The all-time high Aquestive Therapeutics stock closing price was 18.96 on September 07, 2018.
The Aquestive Therapeutics 52-week high stock price is 6.23, which is 135.1% above the current share price.
The Aquestive Therapeutics 52-week low stock price is 2.24, which is 15.5% below the current share price.
The average Aquestive Therapeutics stock price for the last 52 weeks is 3.84.
An investor who bought $1,000 worth of Aquestive Therapeutics stock at the IPO in 2018 would have $-835 today, roughly -1 times their original investment - a -22.69% compound annual growth rate over 7 years.
The all-time high Aquestive Therapeutics stock closing price was 18.96 on September 07, 2018.
The Aquestive Therapeutics 52-week high stock price is 6.23, which is 135.1% above the current share price.
The Aquestive Therapeutics 52-week low stock price is 2.24, which is 15.5% below the current share price.
The average Aquestive Therapeutics stock price for the last 52 weeks is 3.84.